Cyster et al., 1994 - Google Patents
Antigenic determinants encoded by alternatively spliced exons of CD45 are determined by the polypeptide but influenced by glycosylationCyster et al., 1994
View PDF- Document ID
- 14519772690193703779
- Author
- Cyster J
- Fowell D
- Neil Barclay A
- Publication year
- Publication venue
- International Immunology
External Links
Snippet
Antibodies recognising the products of alternatively spliced exons near the N-terminus of the leukocyte common antigen, CD45, have been widely used to distinguish populations of lymphocytes with different functional properties. These alternatively spliced regions contain …
- 102100005499 PTPRC 0 title abstract description 105
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
- C07K16/30—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
- C07K14/70503—Immunoglobulin superfamily
- C07K14/70539—MHC-molecules, e.g. HLA-molecules
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/12—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria
- C07K16/1203—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-negative bacteria
- C07K16/1228—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-negative bacteria from Enterobacteriaceae (F), e.g. Citrobacter, Serratia, Proteus, Providencia, Morganella, Yersinia
- C07K16/1232—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-negative bacteria from Enterobacteriaceae (F), e.g. Citrobacter, Serratia, Proteus, Providencia, Morganella, Yersinia from Escherichia (G)
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay
- G01N33/569—Immunoassay; Biospecific binding assay for micro-organisms, e.g. protozoa, bacteria, viruses
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP6700325B2 (en) | Bispecific antibody molecules with T cells transfected with antigen and their use in medicine | |
Idzerda et al. | Isolation and DNA sequence of a cDNA clone encoding a lymphocyte adhesion receptor for high endothelium. | |
van Endert et al. | A sequential model for peptide binding and transport by the transporters associated with antigen processing | |
Lambris et al. | Dissection of CR1, factor H, membrane cofactor protein, and factor B binding and functional sites in the third complement component. | |
EP0850305B1 (en) | Compounds and methods for diagnosis of tuberculosis | |
JP2021097705A (en) | Antibodies that bind to human programmed death ligand 1 (PD-L1) | |
Stallcup et al. | Characterization of an anti-H-2 monoclonal antibody and its use in large-scale antigen purification. | |
CN111417652A (en) | Chimeric polypeptides and uses thereof | |
GONZÁLEZ et al. | Two different 8 kDa monomers are involved in the oligomeric organization of the native Echinococcus granulosus antigen B | |
CA2212702A1 (en) | Mucosal vascular addressins and uses thereof | |
JPH02295487A (en) | Manifestation sysytem for producing chimera monoclonal antobody | |
US5231167A (en) | Immunoglobulin-binding polypeptides | |
JPH10508463A (en) | Polypeptide having Fc binding ability | |
CA2223269A1 (en) | Hepatocyte growth factor receptor antagonists and uses thereof | |
CN105744944B (en) | Immune system regulator | |
EP0640135A1 (en) | Immunoglobulin binding proteins derived from l protein and their uses | |
US5705398A (en) | Methods for identifying inhibitors of LPS-mediated LBP binding | |
Natvig et al. | A hybrid IgG4-IgG2 immunoglobulin | |
EP0625157B1 (en) | PLATELET GPIIIa P1A1 AND P1A2 EPITOPES, THEIR PREPARATION AND USE | |
Cyster et al. | Antigenic determinants encoded by alternatively spliced exons of CD45 are determined by the polypeptide but influenced by glycosylation | |
WO2008153433A1 (en) | Monoclonal antibodies for detection of mullerian inhibiting substance and uses thereof | |
US5306812A (en) | Immunoglobulin-binding polypeptides | |
CN112262213A (en) | Novel anti-PAD 2 antibodies | |
JP2726264B2 (en) | Assays and antibodies for N-myc proteins | |
Linke et al. | Expression, structure, and location of epitopes of the major surface glycoprotein of Pneumocystis carinii f. sp. carinii |